VA North Texas Health Care System

IMPORTANCE: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection. OBSERVATIONS: No proven effective therapies for this virus currently exist. The rapidly expanding knowledge regarding SARS-CoV-2 virology provides a significant number of potential drug targets. The most promising therapy is remdesivir. Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials. Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended. Current clinical evidence does not support stopping angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients with COVID-19. CONCLUSIONS AND RELEVANCE: The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918. The speed and volume of clinical trials launched to investigate potential therapies for COVID-19 highlight both the need and capability to produce high-quality evidence even in the middle of a pandemic. No therapies have been shown effective to date.

BACKGROUND: Combination therapy with angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) decreases proteinuria; however, its safety and effect on the progression of kidney disease are uncertain. Methods We provided losartan (at a dose of 100 mg per day) to patients with type 2 diabetes, a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 300, and an estimated glomerular filtration rate (GFR) of 30.0 to 89.9 ml per minute per 1.73 m(2) of body-surface area and then randomly assigned them to receive lisinopril (at a dose of 10 to 40 mg per day) or placebo. The primary end point was the first occurrence of a change in the estimated GFR (a decline of ≥ 30 ml per minute per 1.73 m(2) if the initial estimated GFR was ≥ 60 ml per minute per 1.73 m(2) or a decline of ≥ 50% if the initial estimated GFR was <60 ml per minute per 1.73 m(2)), end-stage renal disease (ESRD), or death. The secondary renal end point was the first occurrence of a decline in the estimated GFR or ESRD. Safety outcomes included mortality, hyperkalemia, and acute kidney injury. Results The study was stopped early owing to safety concerns. Among 1448 randomly assigned patients with a median follow-up of 2.2 years, there were 152 primary end-point events in the monotherapy group and 132 in the combination-therapy group (hazard ratio with combination therapy, 0.88; 95% confidence interval [CI], 0.70 to 1.12; P=0.30). A trend toward a benefit from combination therapy with respect to the secondary end point (hazard ratio, 0.78; 95% CI, 0.58 to 1.05; P=0.10) decreased with time (P=0.02 for nonproportionality). There was no benefit with respect to mortality (hazard ratio for death, 1.04; 95% CI, 0.73 to 1.49; P=0.75) or cardiovascular events. Combination therapy increased the risk of hyperkalemia (6.3 events per 100 person-years, vs. 2.6 events per 100 person-years with monotherapy; P<0.001) and acute kidney injury (12.2 vs. 6.7 events per 100 person-years, P<0.001). Conclusions Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy. (Funded by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development; VA NEPHRON-D ClinicalTrials.gov number, NCT00555217.).

Circadian rhythms and the genes that make up the molecular clock have long been implicated in bipolar disorder. Genetic evidence in bipolar patients suggests that the central transcriptional activator of molecular rhythms, CLOCK, may be particularly important. However, the exact role of this gene in the development of this disorder remains unclear. Here we show that mice carrying a mutation in the Clock gene display an overall behavioral profile that is strikingly similar to human mania, including hyperactivity, decreased sleep, lowered depression-like behavior, lower anxiety, and an increase in the reward value for cocaine, sucrose, and medial forebrain bundle stimulation. Chronic administration of the mood stabilizer lithium returns many of these behavioral responses to wild-type levels. In addition, the Clock mutant mice have an increase in dopaminergic activity in the ventral tegmental area, and their behavioral abnormalities are rescued by expressing a functional CLOCK protein via viral-mediated gene transfer specifically in the ventral tegmental area. These findings establish the Clock mutant mice as a previously unrecognized model of human mania and reveal an important role for CLOCK in the dopaminergic system in regulating behavior and mood.

Importance: Bariatric surgery induces significant weight loss for severely obese patients, but there is limited evidence of the durability of weight loss compared with nonsurgical matches and across bariatric procedures. Objectives: To examine 10-year weight change in a large, multisite, clinical cohort of veterans who underwent Roux-en-Y gastric bypass (RYGB) compared with nonsurgical matches and the 4-year weight change in veterans who underwent RYGB, adjustable gastric banding (AGB), or sleeve gastrectomy (SG). Design, Setting, and Participants: In this cohort study, differences in weight change up to 10 years after surgery were estimated in retrospective cohorts of 1787 veterans who underwent RYGB from January 1, 2000, through September 30, 2011 (573 of 700 eligible [81.9%] with 10-year follow-up), and 5305 nonsurgical matches (1274 of 1889 eligible [67.4%] with 10-year follow-up) in mixed-effects models. Differences in weight change up to 4 years were compared among veterans undergoing RYGB (n = 1785), SG (n = 379), and AGB (n = 246). Data analysis was performed from September 9, 2014, to February 12, 2016. Exposures: Bariatric surgical procedures and usual care. Main Outcomes and Measures: Weight change up to 10 years after surgery through December 31, 2014. Results: The 1787 patients undergoing RYGB had a mean (SD) age of 52.1 (8.5) years and 5305 nonsurgical matches had a mean (SD) age of 52.2 (8.4) years. Patients undergoing RYGB and nonsurgical matches had a mean body mass index of 47.7 and 47.1, respectively, and were predominantly male (1306 [73.1%] and 3911 [73.7%], respectively). Patients undergoing RYGB lost 21% (95% CI, 11%-31%) more of their baseline weight at 10 years than nonsurgical matches. A total of 405 of 564 patients undergoing RYGB (71.8%) had more than 20% estimated weight loss, and 224 of 564 (39.7%) had more than 30% estimated weight loss at 10 years compared with 134 of 1247 (10.8%) and 48 of 1247 (3.9%), respectively, of nonsurgical matches. Only 19 of 564 patients undergoing RYGB (3.4%) regained weight back to within an estimated 5% of their baseline weight by 10 years. At 4 years, patients undergoing RYGB lost 27.5% (95% CI, 23.8%-31.2%) of their baseline weight, patients undergoing AGB lost 10.6% (95% CI, 0.6%-20.6%), and patients undergoing SG lost 17.8% (95% CI, 9.7%-25.9%). Patients undergoing RYGB lost 16.9% (95% CI, 6.2%-27.6%) more of their baseline weight than patients undergoing AGB and 9.7% (95% CI, 0.8%-18.6%) more than patients undergoing SG. Conclusions and Relevance: Patients in the Veterans Administration health care system lost substantially more weight than nonsurgical matches and sustained most of this weight loss in the long term. Roux-en-Y gastric bypass induced significantly greater weight loss among veterans than SG or AGB at 4 years. These results provide further evidence of the beneficial association between surgery and long-term weight loss that has been demonstrated in shorter-term studies of younger, predominantly female populations.

IMPORTANCE: Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE: To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS: Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES: Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS: Data from 561 participants were analyzed (alpha tocopherol = 140, memantine = 142, combination = 139, placebo = 140), with 52 excluded because of a lack of any follow-up data. Over the mean (SD) follow-up of 2.27 (1.22) years, ADCS-ADL Inventory scores declined by 3.15 units (95% CI, 0.92 to 5.39; adjusted P = .03) less in the alpha tocopherol group compared with the placebo group. In the memantine group, these scores declined 1.98 units less (95% CI, -0.24 to 4.20; adjusted P = .40) than the placebo group's decline. This change in the alpha tocopherol group translates into a delay in clinical progression of 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period. Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations," with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00235716.

OPINION article Front. Psychiatry, 23 April 2013Sec. Mood Disorders Volume 4 - 2013 | https://doi.org/10.3389/fpsyt.2013.00027

Neurophysiologic processes underlie the uncontrolled, compulsive behaviors defining the addicted state. These"hard-wired"changes in the brain are considered critical for the transition from casual to addictive drug use. This review of preclinical and clinical (primarily neuroimaging) studies will describe how the delineation between pleasure, reward, and addiction has evolved as our understanding of the biologic mechanisms underlying these processes has progressed. Although the mesolimbic dopaminergic efflux associated with drug reward was previously considered the biologic equivalent of pleasure, dopaminergic activation occurs in the presence of unexpected and novel stimuli (either pleasurable or aversive) and appears to determine the motivational state of wanting or expectation. The persistent release of dopamine during chronic drug use progressively recruits limbic brain regions and the prefrontal cortex, embedding drug cues into the amygdala (through glutaminergic mechanisms) and involving the amygdala, anterior cingulate, orbitofrontal cortex, and dorsolateral prefrontal cortex in the obsessive craving for drugs. The abstinent, addicted brain is subsequently primed to return to drug use when triggered by a single use of drug, contextual drug cues, craving, or stress, with each process defined by a relatively distinct brain region or neural pathway. The compulsive drive toward drug use is complemented by deficits in impulse control and decision making, which are also mediated by the orbitofrontal cortex and anterior cingulate. Within this framework, future targets for pharmacologic treatment are suggested.

IMPORTANCE: Exposure to a disaster is common, and one-third or more of individuals severely exposed may develop posttraumatic stress disorder or other disorders. A systematic approach to the delivery of timely and appropriate disaster mental health services may facilitate their integration into the emergency medical response. OBJECTIVE: To review and summarize the evidence for how best to identify individuals in need of disaster mental health services and triage them to appropriate care. EVIDENCE REVIEW: Search of the peer-reviewed English-language literature on disaster mental health response in PsycINFO, PubMed, Cochrane Database of Systematic Reviews, Academic Search Complete, and Google Scholar (inception to September 2012) and PILOTS (inception to February 2013), using a combination of subject headings and text words (Disasters, Natural Disasters, Mental Health, Mental Health Programs, Public Health Services, Mental Disorders, Mental Health Services, Community Mental Health Services, Emergency Services Psychiatric, Emotional Trauma, Triage, and Response). FINDINGS: Unlike physical injuries, adverse mental health outcomes of disasters may not be apparent, and therefore a systematic approach to case identification and triage to appropriate interventions is required. Symptomatic individuals in postdisaster settings may experience new-onset disaster-related psychiatric disorders, exacerbations of preexisting psychopathology, and/or psychological distress. Descriptive disaster mental health studies have found that many (11%-38%) distressed individuals presenting for evaluation at shelters and family assistance centers have stress-related and adjustment disorders; bereavement, major depression, and substance use disorders were also observed, and up to 40% of distressed individuals had preexisting disorders. Individuals with more intense reactions to disaster stress were more likely to accept referral to mental health services than those with less intense reactions. Evidence-based treatments are available for patients with active psychiatric disorders, but psychosocial interventions such as psychological first aid, psychological debriefing, crisis counseling, and psychoeducation for individuals with distress have not been sufficiently evaluated to establish their benefit or harm in disaster settings. CONCLUSION AND RELEVANCE: In postdisaster settings, a systematic framework of case identification, triage, and mental health interventions should be integrated into emergency medicine and trauma care responses.

The authors provide a state-of-the-art review of the epidemiology, pathogenesis, and natural history of Barrett's esophagus and management options for the disorder.

To survive in hostile environments, organisms activate stress-responsive transcriptional regulators that coordinately increase production of protective factors. Hypoxia changes cellular metabolism and thus activates redox-sensitive as well as oxygen-dependent signal transducers. We demonstrate that Sirtuin 1 (Sirt1), a redox-sensing deacetylase, selectively stimulates activity of the transcription factor hypoxia-inducible factor 2 alpha (HIF-2alpha) during hypoxia. The effect of Sirt1 on HIF-2alpha required direct interaction of the proteins and intact deacetylase activity of Sirt1. Select lysine residues in HIF-2alpha that are acetylated during hypoxia confer repression of Sirt1 augmentation by small-molecule inhibitors. In cultured cells and mice, decreasing or increasing Sirt1 activity or levels affected expression of the HIF-2alpha target gene erythropoietin accordingly. Thus, Sirt1 promotes HIF-2 signaling during hypoxia and likely other environmental stresses.

Aberrant epidermal growth factor receptor (EGFR) signaling is common in cancer. Increased expression of wild type and mutant EGFR is a widespread feature of diverse types of cancer. EGFR signaling in cancer has been the focus of intense investigation for decades primarily for two reasons. First, aberrant EGFR signaling is likely to play an important role in the pathogenesis of cancer, and therefore, the mechanisms of EGFR-mediated oncogenic signaling are of interest. Second, the EGFR signaling system is an attractive target for therapeutic intervention. EGFR gene amplification and overexpression are a particularly striking feature of glioblastoma (GBM), observed in approximately 40% of tumors. GBM is the most common primary malignant tumor of the central nervous system in adults. In approximately 50% of tumors with EGFR amplification, a specific EGFR mutant (EGFRvIII, also known as EGFR type III, de2-7, Delta EGFR) can be detected. This mutant is highly oncogenic and is generated from a deletion of exons 2 to 7 of the EGFR gene, which results in an in-frame deletion of 267 amino acids from the extracellular domain of the receptor. EGFRvIII is unable to bind ligand, and it signals constitutively. Although EGFRvIII has the same signaling domain as the wild type receptor, it seems to generate a distinct set of downstream signals that may contribute to an increased tumorigenicity. In this review, we discuss recent progress in key aspects of EGFR signaling in GBM, focusing on neuropathology, signal transduction, imaging of the EGFR, and the role of the EGFR in mediating resistance to radiation therapy in GBM.

BACKGROUND: Dexmedetomidine is a highly selective alpha2-adrenoceptor agonist used for short-term sedation of mechanically ventilated patients. The analgesic profile of dexmedetomidine has not been fully characterized in humans. METHODS: This study was designed to compare the analgesic responses of six healthy male volunteers during stepwise target-controlled infusions of remifentanil and dexmedetomidine. A computer-controlled thermode was used to deliver painful heat stimuli to the volar side of the forearms of the subjects. Six sequential 5-s stimuli (ranging from 41 degrees to 50 degrees C) were delivered in random order. The recorded visual analog scale was used to fit an Emax model. RESULTS: Compared to baseline, remifentanil infusions resulted in a right shift of the sigmoid curve (increased T50, the temperature producing a visual analog scale score of 50% of the maximal effect, from 46.1 degrees C at baseline to 48.4 degrees and 49.1 degrees C during remifentanil infusions) without a change of the steepness of the curve (identical Hill coefficients gamma during baseline and remifentanil). Compared to baseline, dexmedetomidine infusions resulted in both a right shift of the sigmoid curve (increased T50 to 47.2 degrees C) and a decrease in the steepness of the curve (decreased gamma from 3.24 during baseline and remifentanil infusions to 2.45 during dexmedetomidine infusions). There was no difference in the pain responses between baseline and after recovery from remifentanil infusions (identical T50 and gamma). CONCLUSION: As expected, dexmedetomidine is not as effective an analgesic as the opioid remifentanil. The difference in the quality of the analgesia with remifentanil may be a reflection of a different mechanism of action or a consequence of the sedative effect of dexmedetomidine.

OBJECTIVE: Our objective was to test whether natalizumab, an antibody against very late activating antigen (VLA)-4, interferes with central nervous system immune surveillance as assessed by leukocyte cell numbers and cellular phenotypes in cerebrospinal fluid (CSF) and peripheral blood. METHODS: Cell numbers and cellular phenotypes in CSF and peripheral blood were analyzed in multiple sclerosis (MS) patients treated with natalizumab, untreated MS patients, and patients with other neurological disease (OND). JC virus DNA in the CSF and peripheral blood was quantified by kinetic polymerase chain reaction. RESULTS: CSF leukocyte counts, CD4(+) and CD8(+) T cells, CD19(+) B cells, and CD138(+) plasma cells were significantly lower in natalizumab-treated MS patients compared with OND patients and untreated MS patients. JC virus DNA was not detected in CSF or peripheral blood from natalizumab-treated patients. Six months after cessation of natalizumab therapy, low lymphocyte counts in the CSF persisted. The patient with the highest total leukocyte and CD4(+) and CD8(+)T-cell counts in the CSF experienced a clinical relapse. INTERPRETATION: These data suggest that natalizumab treatment results in a prolonged decrease of lymphocytes in the CSF and are consistent with the hypothesis that natalizumab impairs immune surveillance of the central nervous system.

Detection of glycogen in vivo would have utility in the study of normal physiology and many disorders. Presently, the only magnetic resonance (MR) method available to study glycogen metabolism in vivo is (13)C MR spectroscopy, but this technology is not routinely available on standard clinical scanners. Here, we show that glycogen can be detected indirectly through the water signal by using selective radio frequency (RF) saturation of the hydroxyl protons in the 0.5- to 1.5-ppm frequency range downfield from water. The resulting saturated spins are rapidly transferred to water protons via chemical exchange, leading to partial saturation of the water signal, a process now known as chemical exchange saturation transfer. This effect is demonstrated in glycogen phantoms at magnetic field strengths of 4.7 and 9.4 T, showing improved detection at higher field in adherence with MR exchange theory. Difference images obtained during RF irradiation at 1.0 ppm upfield and downfield of the water signal showed that glycogen metabolism could be followed in isolated, perfused mouse livers at 4.7 T before and after administration of glucagon. Glycogen breakdown was confirmed by measuring effluent glucose and, in separate experiments, by (13)C NMR spectroscopy. This approach opens the way to image the distribution of tissue glycogen in vivo and to monitor its metabolism rapidly and noninvasively with MRI.

Proton NMR spectroscopy at 7 Tesla (7T) was evaluated as a new method to quantify human fat composition noninvasively. In validation experiments, the composition of a known mixture of triolein, tristearin, and trilinolein agreed well with measurements by 1H NMR spectroscopy. Triglycerides in calf subcutaneous tissue and tibial bone marrow were examined in 20 healthy subjects by 1H spectroscopy. Ten well-resolved proton resonances from triglycerides were detected using stimulated echo acquisition mode sequence and small voxel (∼0.1 ml), and T1 and T2 were measured. Triglyceride composition was not different between calf subcutaneous adipose tissue and tibial marrow for a given subject, and its variation among subjects, as a result of diet and genetic differences, fell in a narrow range. After correction for differential relaxation effects, the marrow fat composition was 29.1 ± 3.5% saturated, 46.4 ± 4.8% monounsaturated, and 24.5 ± 3.1% diunsaturated, compared with adipose fat composition, 27.1 ± 4.2% saturated, 49.6 ± 5.7% monounsaturated, and 23.4 ± 3.9% diunsaturated. Proton spectroscopy at 7T offers a simple, fast, noninvasive, and painless method for obtaining detailed information about lipid composition in humans, and the sensitivity and resolution of the method may facilitate longitudinal monitoring of changes in lipid composition in response to diet, exercise, and disease. Proton NMR spectroscopy at 7 Tesla (7T) was evaluated as a new method to quantify human fat composition noninvasively. In validation experiments, the composition of a known mixture of triolein, tristearin, and trilinolein agreed well with measurements by 1H NMR spectroscopy. Triglycerides in calf subcutaneous tissue and tibial bone marrow were examined in 20 healthy subjects by 1H spectroscopy. Ten well-resolved proton resonances from triglycerides were detected using stimulated echo acquisition mode sequence and small voxel (∼0.1 ml), and T1 and T2 were measured. Triglyceride composition was not different between calf subcutaneous adipose tissue and tibial marrow for a given subject, and its variation among subjects, as a result of diet and genetic differences, fell in a narrow range. After correction for differential relaxation effects, the marrow fat composition was 29.1 ± 3.5% saturated, 46.4 ± 4.8% monounsaturated, and 24.5 ± 3.1% diunsaturated, compared with adipose fat composition, 27.1 ± 4.2% saturated, 49.6 ± 5.7% monounsaturated, and 23.4 ± 3.9% diunsaturated. Proton spectroscopy at 7T offers a simple, fast, noninvasive, and painless method for obtaining detailed information about lipid composition in humans, and the sensitivity and resolution of the method may facilitate longitudinal monitoring of changes in lipid composition in response to diet, exercise, and disease. Adipose mass and the anatomic distribution of adipose tissue strongly influence the risk of multiple diseases. The fatty acid composition of adipose tissue may also influence predisposition to various disorders including cancer (1Simonsen N. van't Veer P. Strain J.J. Martin-Moreno J.M. Huttunen J.K. Navajas J.F. Martin B.C. Thamm M. Kardinaal A.F. Kok F.J. et al.Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer.Am. J. Epidemiol. 1998; 147: 342-352Crossref PubMed Scopus (136) Google Scholar, 2Shannon J. King I.B. Moshofsky R. Lampe J.W. Li Gao D. Ray R.M. Thomas D.B. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China.Am. J. Clin. Nutr. 2007; 85: 1090-1097Crossref PubMed Scopus (102) Google Scholar), type 2 diabetes (3Storlien L.H. Higgins J.A. Thomas T.C. Brown M.A. Wang H.Q. Huang X.F. Else P.L. Diet composition and insulin action in animal models.Br. J. Nutr. 2000; 83: 85-90Crossref Google Scholar, 4Manco M. Greco A.V. Capristo E. Gniuli D. De Gaetano A. Gasbarrini G. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides.Metabolism. 2000; 49: 220-224Abstract Full Text PDF PubMed Scopus (141) Google Scholar, 5Storlien L.H. Jenkins A.B. Chisholm D.J. Pascoe W.S. Khouri S. Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid.Diabetes. 1991; 40: 280-289Crossref PubMed Google Scholar, 6Meyer K.A. Kushi L.H. Jacobs Jr., D.R. Folsom A.R. Dietary fat and incidence of type 2 diabetes in older Iowa women.Diabetes Care. 2001; 24: 1528-1535Crossref PubMed Scopus (313) Google Scholar), and heart disease (7Hu F.B. Willett W.C. Optimal diets for prevention of coronary heart disease.J. Am. Med. Assoc. 2002; 288: 2569-2578Crossref PubMed Scopus (1165) Google Scholar). Nevertheless, the relations among adipose tissue composition and the risk of disease are controversial and difficult to study, in part because of the traditional requirement for invasive biopsy. Noninvasive analysis of fat composition in humans by 1H NMR spectroscopy would have major advantages, because the study could be integrated into routine exams. Under high-resolution analytical conditions, signals from protons adjacent to double bonds are easily resolved, and it is a relatively simple matter to assess fat composition by 1H NMR spectroscopy (8Zancanaro C. Nano R. Marchioro C. Sbarbati A. Boicelli A. Osculati F. Magnetic resonance spectroscopy investigations of brown adipose tissue and isolated brown adipocytes.J. Lipid Res. 1994; 35: 2191-2199Abstract Full Text PDF PubMed Google Scholar, 9Miyake Y. Yokomizo K. Matsuzaki N. Determination of unsaturated fatty acid composition by high-resolution nuclear magnetic resonance spectroscopy.J. Am. Oil Chem. Soc. 1998; 75: 1091-1094Crossref Google Scholar, 10Guillen M.D. Ruiz A. 1H nuclear magnetic resonance as a fast tool for determining the composition of acyl chains in acylglycerol mixtures.Eur. J. Lipid Sci. Technol. 2003; 105: 502-507Crossref Scopus (100) Google Scholar, 11Knothe G. Kenar J.A. Determination of the fatty acid profile by 1H-NMR spectroscopy.Eur. J. Lipid Sci. Technol. 2004; 106: 88-96Crossref Scopus (347) Google Scholar, 12Yeung D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google Scholar). However, extension of these methods to human applications is challenging because chemical shift resolution observed in vivo at 1.5 or 3.0 Tesla (T) is substantially worse than in analytical spectrometers. Because of the intense current interest in triglyceride composition and metabolism, several alternatives have been suggested, including selective detection of polyunsaturated fatty acids in animal models at 4.7 T (13Lunati E. Farace P. Nicolato E. Righetti C. Marzola P. Sbarbati A. Osculati F. Polyunsaturated fatty acids mapping by 1H MR-chemical shift imaging.Magn. Reson. Med. 2001; 46: 879-883Crossref PubMed Scopus (39) Google Scholar), two-dimensional NMR at 3 T (14Velan S.S. Durst C. Lemieux S.K. Raylman R.R. Sridhar R. Spencer R.G. Hobbs G.R. Thomas M.A. Investigation of muscle lipid metabolism by localized one- and two-dimensional MRS techniques using a clinical 3T MRI/MRS scanner.J. Magn. Reson. Imaging. 2007; 25: 192-199Crossref PubMed Scopus (34) Google Scholar), and 1H-decoupled 13C NMR spectroscopy (15Beckmann N. Brocard J.J. Keller U. Seelig J. Relationship between the degree of unsaturation of dietary fatty acids and adipose tissue fatty acids assessed by natural-abundance 13C magnetic resonance spectroscopy in man.Magn. Reson. Med. 1992; 27: 97-106Crossref PubMed Scopus (26) Google Scholar, 16Dimand R.J. Moonen C.T. Chu S.C. Bradbury E.M. Kurland G. Cox K.L. Adipose tissue abnormalities in cystic fibrosis: noninvasive determination of mono- and polyunsaturated fatty acids by carbon-13 topical magnetic resonance spectroscopy.Pediatr. Res. 1988; 24: 243-246Crossref PubMed Scopus (17) Google Scholar, 17Moonen C.T. Dimand R.J. Cox K.L. The noninvasive determination of linoleic acid content of human adipose tissue by natural abundance carbon-13 nuclear magnetic resonance.Magn. Reson. Med. 1988; 6: 140-157Crossref PubMed Scopus (64) Google Scholar, 18Thomas E.L. Frost G. Barnard M.L. Bryant D.J. Taylor-Robinson S.D. Simbrunner J. Coutts G.A. Burl M. Bloom S.R. Sales K.D. et al.An in vivo 13C magnetic resonance spectroscopic study of the between diet and adipose tissue PubMed Scopus Google Scholar, S. A. In vivo of fatty acids in human adipose tissue using natural abundance 1H 13C MRS at 1.5 clinical applications to dietary 2003; PubMed Scopus (39) Google Scholar). The chemical shift of 13C is a major compared with 1H is by the requirement for and a shift resolution in the 1H in at the fatty acid composition of adipose tissue was on 1H in vivo at the chemical shift of signals from protons adjacent to double of analysis K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google was the of spectroscopic from adjacent resonances with a of at In (8Zancanaro C. Nano R. Marchioro C. Sbarbati A. Boicelli A. Osculati F. Magnetic resonance spectroscopy investigations of brown adipose tissue and isolated brown adipocytes.J. Lipid Res. 1994; 35: 2191-2199Abstract Full Text PDF PubMed Google Scholar), triglyceride was from the protons at by using the protons as the resonances a of at The may result in and the of with resonances in different known as chemical shift The to triglyceride composition using proton spectroscopy would have applications in clinical In study, the by and K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google to fatty acid composition by 1H NMR spectroscopy in was in and to healthy human The fatty acid composition of bone marrow by NMR in study was in with D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google not P. D. J. Lipid composition of human bone marrow as by Lipid Res. Full Text PDF Google of fatty acid composition by The NMR determination of saturated fatty acids in subcutaneous fat agreed well with analysis of subcutaneous about of fatty for about were by compared with in The by to quantify fat composition by 1H NMR (8Zancanaro C. Nano R. Marchioro C. Sbarbati A. Boicelli A. Osculati F. Magnetic resonance spectroscopy investigations of brown adipose tissue and isolated brown adipocytes.J. Lipid Res. 1994; 35: 2191-2199Abstract Full Text PDF PubMed Google Scholar, 9Miyake Y. Yokomizo K. Matsuzaki N. Determination of unsaturated fatty acid composition by high-resolution nuclear magnetic resonance spectroscopy.J. Am. Oil Chem. Soc. 1998; 75: 1091-1094Crossref Google Scholar, 10Guillen M.D. Ruiz A. 1H nuclear magnetic resonance as a fast tool for determining the composition of acyl chains in acylglycerol mixtures.Eur. J. Lipid Sci. Technol. 2003; 105: 502-507Crossref Scopus (100) Google Scholar, 11Knothe G. Kenar J.A. Determination of the fatty acid profile by 1H-NMR spectroscopy.Eur. J. Lipid Sci. Technol. 2004; 106: 88-96Crossref Scopus (347) Google Scholar, 12Yeung D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google Scholar, K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google are easily to human at 1H NMR be The was by the was from to the study. healthy and diabetes or known were or in a 7T were with a to the of a human and echo were of the calf of echo and of stimulated echo acquisition mode voxel (∼0.1 ml), 20 of of and to to was to 1H from tibial bone marrow and subcutaneous fat resonances for relaxation effects, T1 and T2 were in of the T1 was using with in the of to with 7 and T2 was by using from 20 to with were to in the The was or and it was by subjects were the and at the subjects or were from the of the to quantify lipid composition, were by of of double and trilinolein in the and with composition of different of triglyceride were by and in the and were in in were in the of a with magnetic resonance spectroscopy voxel The triglyceride composition was as The 1H chemical shift of in vivo fat resonances from bone marrow and subcutaneous tissue was the was at were by the with of on and for resonance were with its T1 and Lipid composition was evaluated correction for relaxation adipose tissue is of fatty acids as of of double linoleic and A. Relationship of diet to the fatty acid composition of human adipose tissue and J. Clin. Nutr. PubMed Scopus Google Scholar, M. M.A. acid composition of adipose tissue in between subcutaneous J. Clin. Nutr. PubMed Scopus Google Scholar). fatty acids for well of the fatty acids in human adipose fatty fatty and fatty acids for the of these than A. Relationship of diet to the fatty acid composition of human adipose tissue and J. Clin. Nutr. PubMed Scopus Google Scholar). 7 resonances be resolved, as to in from to resonances information about triglyceride the protons at the protons at and at to the and the and protons and are resonances to protons at to a double at protons at and double protons at with the proton at was the fatty acids detected or 2 double of fatty acids for of fat in humans on acid is in it of the triglycerides A. Relationship of diet to the fatty acid composition of human adipose tissue and J. Clin. Nutr. PubMed Scopus Google Scholar). and to the of fatty acids are saturated, monounsaturated, and unsaturated The is diunsaturated, be directly from the of the resonance of the protons with to the resonance of protons to the is from the of proton resonance to the double 2 The the of saturated fatty is as the of fatty acids are be from the of the resonances 3 The in of the for acid for acid for acid for acid and 7 for linoleic acid analysis is to the analysis K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google with the a for unsaturated fat with double bonds was than a Ten lipid resonances are observed in the 7T 1H from for the the proton of the chemical shift is about the lipid resonances were well-resolved at 7T and to high-resolution in K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google Scholar). The in the 1H of subcutaneous fat with and it is in bone marrow from a small voxel (∼0.1 The resonance chemical and from marrow and subcutaneous fat are in and resonance and ± ± ± ± protons to ± ± protons to ± ± protons to ± ± ± ± are to the resonance to correction for by to are the ± in a new The are to the resonance to correction for by to are the ± The of analysis was by in a by and in various from with the the known of trilinolein in the mixture is between the and the with of and were for the not the the known in the and mixture The of the known the was evaluated by also a with of and of fat composition in human subcutaneous tissue and tibial the were for in T1 and T2 as from and experiments, 3 the T1 and T2 from the voxel in subcutaneous with the the T2 between tibial marrow and subcutaneous tissue from on the The T1 and T2 at are in by the protons at different in have different with from and from subcutaneous fat T1 and T2 about on in with tibial bone be because of the of proton these T1 and T2 are for T2 have been for animal fat using spectroscopy sequence K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google at the of bone marrow and calf subcutaneous fat from a healthy by at the voxel well in the fat of the subcutaneous tissue and the 1H is are to of the resonance and as a with the resonance with T2 than the T2 resonances as and to resonance the of the and is not of of in resonances to the fatty acid ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± are ± and are for the stimulated echo acquisition mode sequence in a new The are ± and are for the stimulated echo acquisition mode sequence The of saturated, and fat are in with the of fatty acid and The composition of bone marrow and adipose fat was not with 29.1 ± 3.5% saturated, 46.4 ± 4.8% monounsaturated, and 24.5 ± 3.1% for as compared with 27.1 ± 4.2% saturated, 49.6 ± 5.7% monounsaturated, and 23.4 ± 3.9% for subcutaneous was between tibial marrow and subcutaneous fat in the is the of for the 20 subjects as in In a composition of ± from fatty acid with and ± from fatty acid with was for bone as compared with subcutaneous fat with a composition of 23.4 ± 3.9% for and ± for fat composition in marrow and subcutaneous ± ± ± ± ± ± ± ± ± ± as of saturated, monounsaturated, and as well as the of are are the ± in a new The as of saturated, monounsaturated, and as well as the of are are the ± 1H NMR from human adipose tissue were at The of the 1H at 7T were with of high-resolution (8Zancanaro C. Nano R. Marchioro C. Sbarbati A. Boicelli A. Osculati F. Magnetic resonance spectroscopy investigations of brown adipose tissue and isolated brown adipocytes.J. Lipid Res. 1994; 35: 2191-2199Abstract Full Text PDF PubMed Google Scholar, 9Miyake Y. Yokomizo K. Matsuzaki N. Determination of unsaturated fatty acid composition by high-resolution nuclear magnetic resonance spectroscopy.J. Am. Oil Chem. Soc. 1998; 75: 1091-1094Crossref Google Scholar, 10Guillen M.D. Ruiz A. 1H nuclear magnetic resonance as a fast tool for determining the composition of acyl chains in acylglycerol mixtures.Eur. J. Lipid Sci. Technol. 2003; 105: 502-507Crossref Scopus (100) Google Scholar, 11Knothe G. Kenar J.A. Determination of the fatty acid profile by 1H-NMR spectroscopy.Eur. J. Lipid Sci. Technol. 2004; 106: 88-96Crossref Scopus (347) Google Scholar, 12Yeung D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google or in at 7T K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google Scholar). the was chemical shift in humans is compared with 1.5 T or 3.0 The to protons adjacent to double bonds noninvasive of the fatty acid composition of adipose 13C NMR of human adipose tissue (15Beckmann N. Brocard J.J. Keller U. Seelig J. Relationship between the degree of unsaturation of dietary fatty acids and adipose tissue fatty acids assessed by natural-abundance 13C magnetic resonance spectroscopy in man.Magn. Reson. Med. 1992; 27: 97-106Crossref PubMed Scopus (26) Google Scholar, 16Dimand R.J. Moonen C.T. Chu S.C. Bradbury E.M. Kurland G. Cox K.L. Adipose tissue abnormalities in cystic fibrosis: noninvasive determination of mono- and polyunsaturated fatty acids by carbon-13 topical magnetic resonance spectroscopy.Pediatr. Res. 1988; 24: 243-246Crossref PubMed Scopus (17) Google Scholar, 17Moonen C.T. Dimand R.J. Cox K.L. The noninvasive determination of linoleic acid content of human adipose tissue by natural abundance carbon-13 nuclear magnetic resonance.Magn. Reson. Med. 1988; 6: 140-157Crossref PubMed Scopus (64) Google Scholar, 18Thomas E.L. Frost G. Barnard M.L. Bryant D.J. Taylor-Robinson S.D. Simbrunner J. Coutts G.A. Burl M. Bloom S.R. Sales K.D. et al.An in vivo 13C magnetic resonance spectroscopic study of the between diet and adipose tissue PubMed Scopus Google Scholar, S. A. In vivo of fatty acids in human adipose tissue using natural abundance 1H 13C MRS at 1.5 clinical applications to dietary 2003; PubMed Scopus (39) Google of fat composition, compared with a 1H the unsaturated in a are from the in in vivo at 1.5 abundance 13C NMR is by relatively resolution and compared with 1H spectroscopy for human study. 7T are not However, because the of 7T in is and 1H spectroscopy is routine on it to of 1H spectroscopy at 7T for clinical proton resonances in the chemical shift of are The resonances in the narrow of information about the abundance of protons between or adjacent to double correction for of the of saturated, monounsaturated, and fatty The analysis of lipid composition was by to The of saturated in triglycerides as by 1H NMR spectroscopy at about is in with However, the of fatty acids are was in study, compared with about fatty acids are A. Relationship of diet to the fatty acid composition of human adipose tissue and J. Clin. Nutr. PubMed Scopus Google Scholar, R.J. between the fatty acid composition of the diet and of the adipose tissue in J. Clin. Nutr. PubMed Scopus Google Scholar). the of fatty acids to be was about in study compared with about in may in or with chemical the lipid resonances may the of the signals in vivo are the of 1H from several different fatty acids with different chemical a not the observed high-resolution analytical 1H NMR was to marrow fat composition from in and may in the study of the NMR method the of saturated fatty compared with of the D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google Scholar). as K. J. J. proton magnetic resonance spectroscopy of in adipose tissue at resolution in in Lipid Res. 2008; 49: Full Text Full Text PDF PubMed Scopus Google Scholar), correction for T2 is also and than correction for T1 a of the in T2 correction among the resonances and for it at 20 and is as as at to about correction for T1 for the resonances at 2 The T1 correction is not the is with of is the calf subcutaneous fat relatively proton relaxation than the marrow a on subcutaneous be from the in the between these of adipose as in the in subcutaneous tissue is as with fat of different with and the bone marrow as the tibial and to the Because of the resolution from bone marrow is to from subcutaneous as in is to between analysis of fat and marrow compared with from the or are of diet, and on fatty acid composition R.J. between the fatty acid composition of the diet and of the adipose tissue in J. Clin. Nutr. PubMed Scopus Google Scholar, K. S. and in the fatty acid composition of human subcutaneous J. PubMed Scopus Google Scholar). adipose tissue a of fat and saturated fat compared with subcutaneous fat from the and K. S. and in the fatty acid composition of human subcutaneous J. PubMed Scopus Google Scholar). were not in the current study. Nevertheless, the for subcutaneous fat and for bone from 1H MRS study for 20 subjects is in with a for the of polyunsaturated to fatty acid by in vivo 13C study S. A. In vivo of fatty acids in human adipose tissue using natural abundance 1H 13C MRS at 1.5 clinical applications to dietary 2003; PubMed Scopus (39) Google of calf subcutaneous tissue of subjects The of 1H MRS is it is fast than a for as in is easily localized a and is easily or The resolution and sensitivity of the current 1H analysis also the detection of fat composition variation among healthy subjects be to the in diet and it is the method may be in detection of changes in the composition of fatty acids in response to diet, exercise, and diseases. in would noninvasive human lipid been on fat mass distribution by and techniques than fat In analysis of in fat composition between and subjects, on the calf subcutaneous fat in is than in The to the of fatty acid composition to saturated, monounsaturated, and was on the of polyunsaturated or double in human adipose tissue than to the 1H NMR were to quantify unsaturated fatty acids from fatty acids high-resolution analytical M.D. Ruiz A. 1H nuclear magnetic resonance as a fast tool for determining the composition of acyl chains in acylglycerol mixtures.Eur. J. Lipid Sci. Technol. 2003; 105: 502-507Crossref Scopus (100) Google Scholar, 11Knothe G. Kenar J.A. Determination of the fatty acid profile by 1H-NMR spectroscopy.Eur. J. Lipid Sci. Technol. 2004; 106: 88-96Crossref Scopus (347) Google Scholar, 12Yeung D.K.W. Lam S.L. Griffith J.F. Chan A.B.W. Chen Z. Tsang P.H. Leung P.C. Analysis of bone marrow fatty acid composition using high-resolution proton NMR spectroscopy.Chem. Phys. Lipids. 2008; 151: 103-109Crossref PubMed Scopus (45) Google Scholar). in humans, would the to quantify linoleic and However, at the resolution in these a mixture of is from a of these the of fatty acids as saturated, monounsaturated, or a a chemical shift in the 1H may be it is on of resonances the of interest is to the was not evaluated in study, the of a small voxel (∼0.1 well the bone marrow analysis of resonances a narrow chemical shift to chemical shift the the resonance of protons to the is not by the at resonances at be at the of protons to a double T2 for and for subcutaneous than the resonance sequence the of than and on proton to the and was for the of fat composition in In to composition the well-resolved resonances of human tibial bone marrow and calf subcutaneous fat at 7T could also be as to quantify J. F. of in skeletal muscle by high-resolution spectroscopic using fat as the with Reson. Med. 2008; PubMed Scopus (17) Google Scholar), have interest the to to insulin and D. muscle lipid in insulin and type 2 2004; PubMed Scopus Google Scholar). In 1H MRS study at 7T the acquisition of 1H NMR from subcutaneous fat and from bone marrow is in healthy and the may be to assess triglyceride may facilitate longitudinal monitoring of changes in lipid composition in response to diet, exercise, and disease.

The purpose of this study was to determine the influence of chronic illness, obesity, and type of repair on the likelihood of recurrence following incisional herniorrhaphy. The medical records of 77 patients who underwent elective repair of a midline incisional hernia at the Dallas Veterans Affairs Medical Center between 1991 and 1995 were reviewed. Demographic data, presence of chronic illnesses, type of repair, and presence of recurrence were noted. Ninety-six percent of the patients were men, with an average age of 59 years. More than 50% of the patients had chronic lung or cardiac diseases and more than 40% weighed > or = 120% of their ideal body weight and had a body mass index (BMI) > or = 30. Sixty-two percent of the patients underwent primary reapproximation of the fascia (tissue repair), whereas 38% underwent repair with prosthetic material (prosthetic repair). The overall recurrence rate was 45%, with a median follow-up of 45 months (range 6-73). Seventy-four percent of the recurrences presented within 3 years of repair. The recurrence rate for those patients undergoing a tissue repair was 54%, whereas the recurrence rate following prosthetic repair was 29%. The incidence of recurrence for patients with pulmonary or cardiac disease or diabetes mellitus was similar to that of patients without these illnesses. The percent ideal body weight and BMI of patients who developed a recurrent hernia, particularly following a prosthetic repair, were significantly greater than those of patients whose repairs remained intact. These data strongly support the use of prosthetic repairs for incisional hernias, particularly in patients who are overweight.

The criteria for posttraumatic stress disorder PTSD have changed considerably with the newest edition of the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Changes to the diagnostic criteria from the DSM-IV to DSM-5 include: the relocation of PTSD from the anxiety disorders category to a new diagnostic category named “Trauma and Stressor-related Disorders”, the elimination of the subjective component to the definition of trauma, the explication and tightening of the definitions of trauma and exposure to it, the increase and rearrangement of the symptoms criteria, and changes in additional criteria and specifiers. This article will explore the nosology of the current diagnosis of PTSD by reviewing the changes made to the diagnostic criteria for PTSD in the DSM-5 and discuss how these changes influence the conceptualization of PTSD.

OBJECTIVE: Eosinophilic oesophagitis (EoE) and gastro-oesophageal reflux disease (GORD) can have similar clinical and histological features. Proton pump inhibitors (PPIs) are used to distinguish the disorders, with the assumption that only GORD can respond to PPIs. Oesophageal expression of eotaxin-3 stimulated by Th2 cytokines might contribute to oesophageal eosinophilia in EoE. Th2 cytokine effects on the oesophagus in GORD are not known. The objective of the authors was to explore the molecular mechanisms of Th2 cytokines on eotaxin-3 expression by oesophageal squamous cells from patients with GORD and EoE, and the effects of omeprazole on that eotaxin-3 expression. DESIGN: Using telomerase-immortalised and primary cultures of oesophageal squamous cells from GORD and EoE patients, the authors measured eotaxin-3 protein secretion stimulated by Th2 cytokines (interleukin (IL)-4 and IL-13). Eotaxin-3 promoter constructs were used to study transcriptional regulation. Cytokine-induced eotaxin-3 mRNA and protein expression were measured in the presence or absence of omeprazole. RESULTS: There were no significant differences between EoE and GORD primary cells in cytokine-stimulated eotaxin-3 protein secretion levels. In EoE and GORD cell lines, IL-4 and IL-13 activated the eotaxin-3 promoter, and significantly increased eotaxin-3 mRNA and protein expression. Omeprazole blocked the cytokine-stimulated increase in eotaxin-3 mRNA and protein expression in EoE and GORD cell lines. CONCLUSION: Oesophageal squamous cells from GORD and EoE patients express similar levels of eotaxin-3 when stimulated by Th2 cytokines, and omeprazole blocks that eotaxin-3 expression. These findings suggest that PPIs might have eosinophil-reducing effects independent of effects on acid reflux and that response to PPIs might not distinguish EoE from GORD.

Glioblastomas and brain metastases demonstrate avid uptake of 2-[(18) F]fluoro-2-deoxyglucose by positron emission tomography and display perturbations of intracellular metabolite pools by (1) H MRS. These observations suggest that metabolic reprogramming contributes to brain tumor growth in vivo. The Warburg effect, excess metabolism of glucose to lactate in the presence of oxygen, is a hallmark of cancer cells in culture. 2-[(18) F]Fluoro-2-deoxyglucose-positive tumors are assumed to metabolize glucose in a similar manner, with high rates of lactate formation relative to mitochondrial glucose oxidation, but few studies have specifically examined the metabolic fates of glucose in vivo. In particular, the capacity of human brain cancers to oxidize glucose in the tricarboxylic acid cycle is unknown. Here, we studied the metabolism of human brain tumors in situ. [U-(13) C]Glucose (uniformly labeled glucose, i.e. d-glucose labeled with (13) C in all six carbons) was infused during surgical resection, and tumor samples were subsequently subjected to (13) C NMR spectroscopy. The analysis of tumor metabolites revealed lactate production, as expected. We also determined that pyruvate dehydrogenase, turnover of the tricarboxylic acid cycle, anaplerosis and de novo glutamine and glycine synthesis contributed significantly to the ultimate disposition of glucose carbon. Surprisingly, less than 50% of the acetyl-coenzyme A pool was derived from blood-borne glucose, suggesting that additional substrates contribute to tumor bioenergetics. This study illustrates a convenient approach that capitalizes on the high information content of (13) C NMR spectroscopy and enables the analysis of intermediary metabolism in diverse cancers growing in their native microenvironment.

OBJECTIVE: To determine the role of glucagon action in the metabolic phenotype of untreated insulin deficiency. RESEARCH DESIGN AND METHODS: We compared pertinent clinical and metabolic parameters in glucagon receptor-null (Gcgr(-/-)) mice and wild-type (Gcgr(+/+)) controls after equivalent destruction of β-cells. We used a double dose of streptozotocin to maximize β-cell destruction. RESULTS: Gcgr(+/+) mice became hyperglycemic (>500 mg/dL), hyperketonemic, polyuric, and cachectic and had to be killed after 6 weeks. Despite comparable β-cell destruction in Gcgr(-/-) mice, none of the foregoing clinical or laboratory manifestations of diabetes appeared. There was marked α-cell hyperplasia and hyperglucagonemia (~1,200 pg/mL), but hepatic phosphorylated cAMP response element binding protein and phosphoenolpyruvate carboxykinase mRNA were profoundly reduced compared with Gcgr(+/+) mice with diabetes--evidence that glucagon action had been effectively blocked. Fasting glucose levels and oral and intraperitoneal glucose tolerance tests were normal. Both fasting and nonfasting free fatty acid levels and nonfasting β-hydroxy butyrate levels were lower. CONCLUSIONS: We conclude that blocking glucagon action prevents the deadly metabolic and clinical derangements of type 1 diabetic mice.